Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3053-3058, July 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, C.
Right arrow Articles by Dong, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, C.
Right arrow Articles by Dong, Z.
[Cancer Research 59, 3053-3058, July 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Arsenic Induces Apoptosis through a c-Jun NH2-Terminal Kinase-dependent, p53-independent Pathway1

Chuanshu Huang, Wei-ya Ma, Jingxia Li and Zigang Dong2

The Hormel Institute, University of Minnesota, Austin, Minnesota 55912

Arsenic has been used as an effective chemotherapy agent for some human cancers, such as acute promyelocytic leukemia. In this study, we found that arsenic induces activation of c-Jun NH2-terminal kinases (JNKs) at a similar dose range for induction of apoptosis in JB6 cells. In addition, we found that arsenic did not induce p53-dependent transactivation. Similarly, there was no difference in apoptosis induction between cells with p53 +/+ or p53 -/-. In contrast, arsenic-induced apoptosis was almost totally blocked by expression of a dominant-negative mutant of JNK1. These results suggest that the activation of JNKs is involved in arsenic-induced apoptosis of JB6 cells. Taken together with previous findings that p53 mutations are involved in ~50% of all human cancers and nearly all chemotherapeutic agents kill cancer cells mainly by apoptotic induction, we suggest that arsenic may be a useful agent for the treatment of cancers with p53 mutation.




This article has been cited by other articles:


Home page
BloodHome page
E. Fox, B. I. Razzouk, B. C. Widemann, S. Xiao, M. O'Brien, W. Goodspeed, G. H. Reaman, S. M. Blaney, A. J. Murgo, F. M. Balis, et al.
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Blood, January 15, 2008; 111(2): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Song, J. Li, D. Zhang, Z.-g. Liu, J. Ye, Q. Zhan, H.-M. Shen, M. Whiteman, and C. Huang
IKK{beta} programs to turn on the GADD45{alpha}-MKK4-JNK apoptotic cascade specifically via p50 NF-{kappa}B in arsenite response
J. Cell Biol., November 20, 2006; 175(4): 607 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Zhang, L. Song, J. Li, K. Wu, and C. Huang
Coordination of JNK1 and JNK2 Is Critical for GADD45{alpha} Induction and Its Mediated Cell Apoptosis in Arsenite Responses
J. Biol. Chem., November 10, 2006; 281(45): 34113 - 34123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ding, J. Li, C. Xue, K. Wu, W. Ouyang, D. Zhang, Y. Yan, and C. Huang
Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells
J. Biol. Chem., August 25, 2006; 281(34): 24405 - 24413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Ouyang, Q. Ma, J. Li, D. Zhang, Z.-g. Liu, A. K. Rustgi, and C. Huang
Cyclin D1 Induction through I{kappa}B Kinase {beta}/Nuclear Factor-{kappa}B Pathway Is Responsible for Arsenite-Induced Increased Cell Cycle G1-S Phase Transition in Human Keratinocytes
Cancer Res., October 15, 2005; 65(20): 9287 - 9293.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. McCollum, P. C. Keng, J. C. States, and M. J. McCabe Jr.
Arsenite Delays Progression through Each Cell Cycle Phase and Induces Apoptosis following G2/M Arrest in U937 Myeloid Leukemia Cells
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Zhou, Y. Jing, M. Styblo, Z. Chen, and S. Waxman
Glutathione-S-transferase {pi} inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism
Blood, February 1, 2005; 105(3): 1198 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Ivanov and T. K. Hei
Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Davison, K. K. Mann, S. Waxman, and W. H. Miller Jr
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells
Blood, May 1, 2004; 103(9): 3496 - 3502.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. T. Y. Lau, M. Li, R. Xie, Q.-Y. He, and J.-F. Chiu
Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells
Carcinogenesis, January 1, 2004; 25(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Zhang, M. I. Dawson, Y. Ning, L. Polin, R. E. Parchment, T. Corbett, A. N. Mohamed, K.-C. Feng, L. Farhana, A. K. Rishi, et al.
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog
Blood, November 15, 2003; 102(10): 3743 - 3752.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. E. Muscarella, K. A. O'Brien, A. T. Lemley, and S. E. Bloom
Reversal of Bcl-2-Mediated Resistance of the EW36 Human B-Cell Lymphoma Cell Line to Arsenite- and Pesticide-Induced Apoptosis by PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor
Toxicol. Sci., July 1, 2003; 74(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Raffoux, P. Rousselot, J. Poupon, M.-T. Daniel, B. Cassinat, R. Delarue, A.-L. Taksin, D. Rea, A. Buzyn, A. Tibi, et al.
Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia
J. Clin. Oncol., June 15, 2003; 21(12): 2326 - 2334.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. I. Salim, H. Wanibuchi, K. Morimura, M. Wei, M. Mitsuhashi, K. Yoshida, G. Endo, and S. Fukushima
Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice
Carcinogenesis, February 1, 2003; 24(2): 335 - 342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Muscarella and S. E. Bloom
Cross-linking of Surface IgM in the Burkitt's Lymphoma Cell Line ST486 Provides Protection against Arsenite- and Stress-induced Apoptosis That Is Mediated by ERK and Phosphoinositide 3-Kinase Signaling Pathways
J. Biol. Chem., January 31, 2003; 278(6): 4358 - 4367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Huang, J. Li, Q. Zhang, and X. Huang
Role of Bioavailable Iron in Coal Dust-Induced Activation of Activator Protein-1 and Nuclear Factor of Activated T Cells: Difference between Pennsylvania and Utah Coal Dusts
Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 568 - 574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Huang, J. Li, Q. Ke, S. S. Leonard, B.-H. Jiang, X.-S. Zhong, M. Costa, V. Castranova, and X. Shi
Ultraviolet-induced Phosphorylation of p70S6K at Thr389 and Thr421/Ser424 Involves Hydrogen Peroxide and Mammalian Target of Rapamycin but not Akt and Atypical Protein Kinase C
Cancer Res., October 15, 2002; 62(20): 5689 - 5697.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. J. Kim, M.-S. Kim, K.-B. Kim, K.-W. Kim, Y.-M. Hong, I.-K. Kim, H.-W. Lee, and Y.-K. Jung
Sensitizing effects of cadmium on TNF-{alpha}- and TRAIL-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53
Carcinogenesis, September 1, 2002; 23(9): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. E. Muscarella and S. E. Bloom
Differential Activation of the c-Jun N-Terminal Kinase Pathway in Arsenite-Induced Apoptosis and Sensitization of Chemically Resistant Compared to Susceptible B-Lymphoma Cell Lines
Toxicol. Sci., July 1, 2002; 68(1): 82 - 92.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
W. H. Miller Jr.
Molecular Targets of Arsenic Trioxide in Malignant Cells
Oncologist, April 1, 2002; 7(90001): 14 - 19.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. O'Dwyer
Multifaceted Approach to the Treatment of Bcr-Abl-Positive Leukemias
Oncologist, April 1, 2002; 7(90001): 30 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, W.-Y. Ma, A. Kaji, A. M. Bode, and Z. Dong
Requirement of ATM in UVA-induced Signaling and Apoptosis
J. Biol. Chem., January 25, 2002; 277(5): 3124 - 3131.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Qu, C. D. Bortner, T. Sakurai, M. J. Hobson, and M. P. Waalkes
Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway
Carcinogenesis, January 1, 2002; 23(1): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Maeda, S. Hori, H. Nishitoh, H. Ichijo, O. Ogawa, Y. Kakehi, and A. Kakizuka
Tumor Growth Inhibition by Arsenic Trioxide (As2O3) in the Orthotopic Metastasis Model of Androgen-independent Prostate Cancer
Cancer Res., July 1, 2001; 61(14): 5432 - 5440.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Chen, M. Nomura, Q.-B. She, W.-Y. Ma, A. M. Bode, L. Wang, R. A. Flavell, and Z. Dong
Suppression of Skin Tumorigenesis in c-Jun NH2-Terminal Kinase-2-Deficient Mice
Cancer Res., May 1, 2001; 61(10): 3908 - 3912.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. McCabe Jr., K. P. Singh, S. A. Reddy, B. Chelladurai, J. G. Pounds, J. J. Reiners Jr., and J. C. States
Sensitivity of Myelomonocytic Leukemia Cells to Arsenite-Induced Cell Cycle Disruption, Apoptosis, and Enhanced Differentiation Is Dependent on the Inter-Relationship between Arsenic Concentration, Duration of Treatment, and Cell Cycle Phase
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 724 - 733.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Mandlekar, R. Yu, T.-H. Tan, and A.-N. T. Kong
Activation of Caspase-3 and c-Jun NH2-terminal Kinase-1 Signaling Pathways in Tamoxifen-induced Apoptosis of Human Breast Cancer Cells
Cancer Res., November 1, 2000; 60(21): 5995 - 6000.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Hossain, A. A. Akhand, M. Kato, J. Du, K. Takeda, J. Wu, K. Takeuchi, W. Liu, H. Suzuki, and I. Nakashima
Arsenite Induces Apoptosis of Murine T Lymphocytes Through Membrane Raft-Linked Signaling for Activation of c-Jun Amino-Terminal Kinase
J. Immunol., October 15, 2000; 165(8): 4290 - 4297.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer
Mitochondrion as a Novel Target of Anticancer Chemotherapy
J Natl Cancer Inst, July 5, 2000; 92(13): 1042 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Huang, J. Li, W.-Y. Ma, and Z. Dong
JNK Activation Is Required for JB6 Cell Transformation Induced by Tumor Necrosis Factor-alpha but Not by 12-O-Tetradecanoylphorbol-13-Acetate
J. Biol. Chem., October 15, 1999; 274(42): 29672 - 29676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Chen, Y. Lu, Z. Zhang, V. Vallyathan, M. Ding, V. Castranova, and X. Shi
Opposite Effect of NF-kappa B and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite
J. Biol. Chem., March 30, 2001; 276(14): 11414 - 11419.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.